Part (iii) Estimated trends of injecting drug use
Country | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | Drug use [1] | Method [1] |
---|
Czech Republic | : | : | 3.73 | 4.1 | 3.97 | 4 | IDU | TM |
Greece | : | 1.29 | 1.4 | 1.26 | 1.3 | 1.32 | IDU | CR |
Cyprus | : | : | 1.03 | 0.63 | 0.57 | 1.05 | IDU | TP |
United Kingdom | : | : | 4.18 | 3.95 | 3.52 | : | IDU | OT |
Norway | 4.05 | 3.45 | 3.25 | 3.18 | 3.3 | : | IDU | MM |
Notes:
: indicates data not available |
Data represents a selection based on the availablity of the same calculation method over the time. In some countries more estimates might be available. The selection was made in order for the trend to be unbiased. In some countries data are insufficient to report. |
Target groups may vary between countries owing to different methods and data sources; therefore comparisons should be made with caution. |
[1] - IDU = Injecting drug use. TM = Treatment Multiplier ; HM = HIV Multiplier ; MM = Mortality Multiplier ; MI = Multivariate Indicator Method ; PM = Police Multiplier ; TP = Truncated Poisson ; CM = Combined Methods. | Related links:
SB2008: Figure PDU-5 |
For more details see Tables PDU-1, PDU-102 and PDU-103 in the Statistical bulletin 2009. |
See also ‘General notes for interpreting data’ on the Explanatory notes and help page |
See also EMCDDA project (2003): National prevalence estimates of problem drug use in the European Union, 1995–2000, CT.00.RTX.23, EMCDDA, Lisbon, coordinated by the Institut für Therapieforschung, Munich. | Sources:
Reitox national focal points |
2008 REITOX National Reports - Fonte PDU template |
(see the help page for information about formats etc.)